Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Pheochromocytoma 2Neoplasms 1Neoplasm Metastasis 1Endocrine System Diseases 1

Interventions

gallium Ga 68 dotatate 3Specimen Handling 3Temozolomide 2Radiotherapy 2Magnetic Resonance Spectroscopy 26-fluorodopamine 2tipifarnib 1talazoparib 1pazopanib 1olaparib 1lutetium Lu 177 dotatate 1guadecitabine 1fostamatinib 1fluorodopa F 18 1Tamoxifen 1Surgical Procedures, Operative 1Ritonavir 1Oxaliplatin 1Nivolumab 1Leucovorin 1Ipilimumab 1Indinavir 1Fluorodeoxyglucose F18 1Floxuridine 1Doxorubicin 1Contrast Media 1Cisplatin 1CTLA-4 Antigen 1Biopsy 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Pheochromocytoma × 6-fluorodopamine × Clear all
NCT00004847 2026-06-03

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

NCT00028106 2017-07-02

131MIBG to Treat Malignant Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
32 enrolled
Endocrine

Neoplasm Metastasis, Neoplasms, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡